In biotechnology, developing a new cutting-edge treatment that will help millions of Americans, and doing it faster than anyone else, is what you’re supposed to do. But being a thought leader in the field is who you are.
When an American biotechnology company needed to obtain meaningful context on the current treatment landscape for a disease for which they had a promising new treatment under development, they came to Guidepoint to field a large study of selected U.S. physicians.
The goal: ensure they would be in the best possible position to present a comprehensive overview of the disease at an upcoming medical conference.
Having just two weeks to complete the assignment, Guidepoint expedited its survey process:
Review and refine the questionnaire to maximize its effectiveness and program the survey
Use our network to identify thousands of potential participants for this quantitative study, including gastroenterologists, endocrinologists, and other types of specialists. (To match client specifications, we rapidly custom-recruited from one specialty.)
Launch the survey and collect responses from a fully vetted, 300-physician panel
Produce a 34-page report with study methodology and data tables
The report reflected the client’s goal, as it offered a window into the current state of the disease from the treating physician’s point of view.
Data included: physician time spent managing and treating patients for this disease; awareness of medical guidelines and opinions as to their usefulness; screening and diagnosis protocols used; and treatments prescribed. The survey findings were critical input to the upcoming presentation.
Guidepoint’s skilled survey team provided the quick resolution the client was seeking. Later, the satisfied client confided that it was “exactly what we were looking for.”